• Return to Headlines

Downtrend Call Working As Incyte Corp Stock Falls 19.5% (INCY)

By Amy Schwartz

SmarTrend identified a Downtrend for Incyte Corp (NASDAQ:INCY) on March 19th, 2018 at $87.42. In approximately 4 weeks, Incyte Corp has returned 19.50% as of today's recent price of $70.37.

Incyte Corp share prices have moved between a 52-week high of $153.15 and a 52-week low of $61.30 and are now trading 15% above that low price at $70.37 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.9% while the 50-day MA has declined 0.2%.

Incyte Corporation is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Incyte Corp.

Log in and add Incyte Corp (INCY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights incyte corp

Ticker(s): INCY